Serum phosphatidylcholine is lower among breast cancer patients on systemic chemotherapy
Li, Xin, Lim, John, Kolatkar, Anand, Welter, Lisa, Waitman, Kathryn, Hwang, Eun-Sil Shelley, Lu, Janice M., Kuhn, Peter, Nieva, Jorge J.
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Tolerance and activity of oxaliplatin with protracted topotecan infusion in patients with previously treated ovarian cancer. A phase I study
Hochster, Howard, Chen, Thomas T, Lu, Janice M, Hills, Day, Sorich, Joan, Escalon, Juliet, Ivy, Percy, Liebes, Leonard, Muggia, Franco
Published in Gynecologic oncology (01.03.2008)
Published in Gynecologic oncology (01.03.2008)
Get full text
Journal Article
Interplay between B cell and GABA metabolism (GABAm) and association with immune evasion in breast carcinoma (BC)
Chow, Frances Elaine, Kang, Irene, Yin, Jun, Farrell, Alex, Martirosian, Vahan, Jayachandran, Priya, Roussos Torres, Evanthia T., Lu, Janice M., Lenz, Heinz-Josef, Ma, Cynthia X., McArthur, Heather L., Basho, Reva K, Spetzler, David, Neman, Josh
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Is there a role for 21-gene recurrence score in mucinous carcinoma of breast?
Yap, Kelly Khai Li, Koc, Melissa, Lu, Janice M., Spicer, Darcy V.
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Phase II trial of metronomic capecitabine and cyclophosphamide with lapatinib and trastuzumab in patients with HER2-positive metastatic breast cancer
Kang, Irene, Spicer, Darcy V., Lu, Janice M., Groshen, Susan G., Tsao-Wei, Denice, Garcia, Agustin A.
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Comprehensive characterization of androgen receptor expression in breast cancer
Jayachandran, Priya, Deshmukh, Sachin, Wu, Sharon, Enriquez, Kathryn Therese, Kang, Irene, Xiu, Joanne, Farrell, Alex Patrick, Battaglin, Francesca, Mittal, Pooja, Lu, Janice M., Soni, Shivani, Zhang, Wu, Millstein, Joshua, Ma, Cynthia X., Graff, Stephanie L., Radovich, Milan, Lenz, Heinz-Josef, Spicer, Darcy V., Sledge, George W., Roussos Torres, Evanthia T.
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Targeting HER2-positive metastatic breast cancer with ARX788, a novel anti-HER2 antibody-drug conjugate in patients whose disease is resistant or refractory to T-DM1, and/or T-DXd, and/or tucatinib-containing regimens
Lu, Janice M., Kalinsky, Kevin, Tripathy, Debu, Sledge, George W., Gradishar, William John, O'Regan, Ruth, O'Shaughnessy, Joyce, Modi, Shanu, Park, Haeseong, McCartney, Amelia, Frentzas, Sophia, Shannon, Catherine M., Eek, Richard Wilhelm, Martin, Miguel, Curigliano, Giuseppe, Jerusalem, Guy Heinrich Maria, Huang, Chiun-Sheng, Press, Michael F., Tolaney, Sara M., Hurvitz, Sara A.
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Subgroup analysis of patients with no prior chemotherapy in EMERALD: A phase 3 trial evaluating elacestrant, an oral selective estrogen receptor degrader (SERD), versus investigator’s choice of endocrine monotherapy for ER+/HER2-advanced/metastatic breast cancer (mBC)
Kaklamani, Virginia G., Bardia, Aditya, Aftimos, Philippe Georges, Cortes, Javier, Lu, Janice M., Neven, Patrick, Streich, Guillermo, Montero, Alberto J., Forget, Frederic, Mouret-Reynier, Marie-Ange, Sohn, Joohyuk, Taylor, Donatienne, Harnden, Kathleen Kiernan, Khong, Hung T., Kocsis, Judit, Dalenc, Florence, Dillon, Patrick Michael, Tonini, Giulia, Grzegorzewski, Kris, Bidard, François-Clement
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Biomarker analysis from a phase I study using gedatolisib+palbociclib+hormone therapy in ER+/HER2- metastatic breast cancer (mBC)
Wesolowski, Robert, Pathan, Nuzhat, Zhu, Zhou, Stringer-Reasor, Erica Michelle, Han, Hyo S., Dees, Elizabeth Claire, Bardia, Aditya, Layman, Rachel M., Weise, Amy, Kabos, Peter, Lu, Janice M., Kern, Kenneth Alan, Pierce, Kristen J., Rugo, Hope S.
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Molecular characterization of the Ras-MAPK pathway in metastatic breast cancer
Tiu-lim, Justin Wayne Wong, Yin, Jun, Xiu, Joanne, Korn, Wolfgang Michael, Lenz, Heinz-Josef, In, Gino Kim, Roussos Torres, Evanthia T., Lu, Janice M., Spicer, Darcy V., Xia, Bing, Hoon, Dave S. B., Krill-Jackson, Elisa, Heeke, Arielle Lutterman, Sammons, Sarah, Isaacs, Claudine, Ademuyiwa, Foluso Olabisi, Ma, Cynthia X., Tan, Antoinette R., Kang, Irene
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Safety and unique pharmacokinetic profile of ARX788, a site-specific ADC, in heavily pretreated patients with HER2-overexpresing solid tumors: Results from two phase 1 clinical trials
Hurvitz, Sara A., Park, Haeseong, Frentzas, Sophia, Shannon, Catherine M., Cuff, Katharine, Eek, Richard Wilhelm, Budd, George Thomas, McCartney, Amelia, O'Shaughnessy, Joyce, Lu, Janice M., Zhang, Jian, Ji, Dongmei, Shen, Weina, Li, Matt, Yan, Jinchun, Xia, Gang, Ji, Yanping, Yao, Sulan, Xiong, Gaozhun, Hu, Xichun
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Review of next generation sequencing outcomes in patients with metastatic breast cancer
Kang, Irene, D'souza, Anishka, Spicer, Darcy V., Russell, Christy Ann, Lang, Julie E., Nelson, Maria, Silberman, Howard, Lu, Janice M.
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Intraperitoneal therapy as consolidation for patients with ovarian cancer and negative reassessment after platinum-based chemotherapy
Lu, M Janice, Sorich, Joan, Hazarika, Maitreyee, Kim, Mimi, Del Priore, Giuseppe, Jacobs, Allan J, Chiang, Chang, Liu, Paul C, Fusco, Eileen, Curtin, John P, Muggia, Franco M
Published in Hematology/oncology clinics of North America (01.08.2003)
Published in Hematology/oncology clinics of North America (01.08.2003)
Get more information
Journal Article
Interim results from the full population of the phase 3b CompLEEment-1 study of ribociclib (RIBO) plus letrozole (LET) in the treatment of HR+/HER2– advanced breast cancer (ABC)
DeLaurentiis, Michelino, Borstnar, Simona, Campone, Mario, Warner, Ellen, Bofill, Salvador, Jacot, William, Dent, Susan Faye, Martin, Miguel, Ring, Alistair E., Cottu, Paul H., Lu, Janice M., Ciruelos, Eva, Azim, Hamdy A., Chatterjee, Sanjoy, Zhou, Katie, Wu, Jiwen, Ankrah, Nii, Zamagni, Claudio
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Updated results from the phase IIIb complement-1 study of ribociclib (RIB) plus letrozole (LET) in the treatment of HR+, HER2-advanced breast cancer (ABC)
De Laurentiis, Michelino, Borstnar, Simona, Campone, Mario, Warner, Ellen, Salvador Bofill, Javier, Jacot, William, Dent, Susan Faye, Martin, Miguel, Ring, Alistair E., Cottu, Paul H., Lu, Janice M., Ciruelos, Eva, Azim, Hamdy A., Chatterjee, Sanjoy, Zhou, Katie, Wu, Jiwen, Ankrah, Nii, Zamagni, Claudio
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Phase Ib study of gedatolisib in combination with palbociclib and endocrine therapy (ET) in women with estrogen receptor (ER) positive (+) metastatic breast cancer (MBC) (B2151009)
Forero-Torres, Andres, Han, Heather, Dees, Elizabeth Claire, Wesolowski, Robert, Bardia, Aditya, Kabos, Peter, Layman, Rachel M., Lu, Janice M., Kern, Kenneth Alan, Perea, Rachelle, Pierce, Kristen J., Houk, Brett, Pathan, Nuzhat, Rugo, Hope S.
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Circulating tumor cells and genomic profiling of patients with ERBB2 mutant, HER2 non-amplified metastatic breast cancer treated with neratinib
D'souza, Anishka, Shishedo, Stephanie, Spicer, Darcy V., Welter, Lisa, Jiang, Yuanfei, Hyman, David Michael, Solit, David B., Ma, Cynthia X., Bose, Ron, Cutler, Richard E., Eli, Lisa, Hicks, James B, Kuhn, Peter, Lu, Janice M.
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Ribociclib (RIBO) + letrozole (LET) in patients (pts) with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) advanced breast cancer (ABC) with no prior endocrine therapy (ET) for ABC: Preliminary results from the phase 3b CompLEEment-1 trial
DeLaurentiis, Michelino, Neven, Patrick, Jerusalem, Guy Heinrich Maria, Bachelot, Thomas Denis, Jacot, William, Dent, Susan Faye, Colleoni, Marco, Prat, Aleix, Martin, Miguel, Ring, Alistair E., Cottu, Paul H., Lu, Janice M., Azim, Hamdy A., Zhou, Katie, Wu, Jiwen, Zarate, Juan Pablo, Zamagni, Claudio
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article